SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001694665-23-000150
Filing Date
2023-08-21
Accepted
2023-08-21 07:43:35
Documents
15
Period of Report
2023-08-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evlo-20230814.htm   iXBRL 8-K 32365
2 EX-10.1 ex101-eveloxretentionbonus.htm EX-10.1 13024
6 evlo-20230814_g1.jpg GRAPHIC 7885
7 image_1.jpg GRAPHIC 20050
  Complete submission text file 0001694665-23-000150.txt   229890

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20230814.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20230814_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20230814_pre.xml EX-101.PRE 13049
9 EXTRACTED XBRL INSTANCE DOCUMENT evlo-20230814_htm.xml XML 2815
Mailing Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 500 CAMBRIDGE MA 02139 617-577-0300
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38473 | Film No.: 231187351
SIC: 2834 Pharmaceutical Preparations